Embecta Corp
Embecta Corp (EMBC) Covered Calls
Embecta Corp trades in the Medical Instruments & Supplies industry with an IV Rank of 80.16%, high versus the past year. EMBC's highest covered call setup is the $10.00 strike expiring Feb 19, 2027, sorted by theoretical annualized return. It's 53.14% out of the money with 100 days to expiration, a 54.67% return until expiration, and a 199.55% theoretical annualized return. Across the setups shown, annualized returns run from 65.40% to 199.55% at strikes between $7.50 and $10.00, with 37 to 100 days to expiration, as of Nov 11, 2026.
Read more
Running EMBC covered calls helps you generate income from Embecta Corp shares you already own, turning a long stock position into a yield producing asset. A covered call means holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike. Use our scanner to find the best EMBC covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call pairs limited risk with a clear income profile. If EMBC stays below the strike at expiration, you keep the premium and the shares. If it rises above, you deliver the stock at the strike and still pocket the premium. Selling EMBC covered calls works best when implied volatility is elevated, since richer premiums improve the risk reward. Key inputs include strike selection relative to delta, days to expiration, annualized return, and probability of assignment, all of which determine whether a given EMBC covered call is worth writing.
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.
| 2027-02-19 | 100 | 10.00 | 53.14 | 0.10 | 0.45 | 357.00 | 54.67 | 199.55 | -1.53 | +0.21 | 116 | 0.35 |
| 2026-12-18 | 37 | 7.50 | 14.85 | 0.20 | 0.40 | 117.00 | 17.92 | 176.75 | -3.06 | +0.33 | 125 | 0.20 |
| 2027-02-19 | 100 | 7.50 | 14.85 | 0.20 | 0.90 | 117.00 | 17.92 | 65.40 | -3.06 | +0.42 | 335 | 0.70 |
As of Nov 11, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →Stock Statistics
- IndustryMedical Instruments & Supplies
- SectorHealthcare
- IV Rank80.16% High
- Market cap (M$)366
- 52 weeks high-56.35%
- 52 weeks low133.21%
- Analyst recommendationHold
3.20 - Target price$4.00
-38.08% below the current stock price - Dividend—
- Payout ratio37.05%
- Earnings date2026-11-24
- P/E4.35
- Future P/E3.66
- EPS (ttm)1.48
- EPS growth next 5 years-12.88%
As of Nov 13, 2026